Oral therapy

Two Oral MS Drugs in Final Human Testing Stage

People with MS have long been waiting for the day when they can set aside their injection routines and take medication orally. It would drastically change their treatment schedules and outlook for the better. Two promising medications, oral cladribine and fingolimod are in Phase III trials (final testing stage) and are expected to be receiving approvals in Canada in about one year’s time.

Click here to view a summary of the two oral therapies based on data presented at the 2009 American Academy of Neurology annual meeting. 

We will continue to keep you updated on the latest information on oral therapy in our News-feed and What’s New section.

Source:
Medical Update Memo. Multiple Sclerosis Society of Canada. Available at: http://www.mssociety.ca/en/research/medmmo_20090526.htm.